Transcription Factors 818 個 (2013/1/24 現在 )

Size: px
Start display at page:

Download "Transcription Factors 818 個 (2013/1/24 現在 )"

Transcription

1 Transcription Factors 818 個 (2013/1/24 現在 ) 遺伝子シンボル説明 FXC_PID 価格 FHC_PID 価格 AEBP2 AE binding protein 2, transcript variant 2 FXC30523M 50,000 FHC ,000 AHR aryl hydrocarbon receptor FXC ,000 FHC ,000 AHRR aryl-hydrocarbon receptor repressor FXC ,000 FHC ,000 ALX1 ALX homeobox 1 FXC24829M 50,000 FHC ,000 ALX4 ALX homeobox 4 FXC ,000 FHC ,000 AR Androgen receptor (Dihydrotestosterone receptor)(nuclear rece FXC11949M 50,000 FHC ,000 AR Androgen receptor (Dihydrotestosterone receptor)(nuclear rece FXC11950M 50,000 FHC ,000 AR androgen receptor FXC ,000 FHC ,000 ARNT aryl hydrocarbon receptor nuclear translocator FXC ,000 FHC ,000 ARNT2 aryl-hydrocarbon receptor nuclear translocator 2 FXC ,000 FHC ,000 ARNTL Aryl hydrocarbon receptor nuclear translocator-like protein 1 (B FXC ,000 FHC ,000 ARNTL2 aryl hydrocarbon receptor nuclear translocator-like 2 FXC12305M 50,000 FHC ,000 ASCL1 achaete-scute complex homolog 1 (Drosophila) FXC ,000 FHC ,000 ASCL2 achaete-scute complex homolog 2 (Drosophila) FXC24115M 50,000 FHC ,000 ASCL3 achaete-scute complex homolog 3 (Drosophila) FXC ,000 FHC ,000 ATF1 activating transcription factor 1 FXC10950M 50,000 FHC ,000 ATF2 activating transcription factor 2 FXC ,000 FHC ,000 ATF3 Cyclic AMP-dependent transcription factor ATF-3 (camp-depen FXC ,000 FHC ,000 ATF4 activating transcription factor 4 (tax-responsive enhancer eleme FXC ,000 FHC ,000 ATF5 activating transcription factor 5 FXC ,000 FHC ,000 ATF6 activating transcription factor 6 FXC20682M 50,000 FHC ,000 ATF7 activating transcription factor 7 FXC ,000 FHC ,000 ATOH1 atonal homolog 1 (Drosophila) FXC ,000 FHC ,000 ATOH8 atonal homolog 8 (Drosophila) FXC ,000 FHC ,000 ATRX alpha thalassemia/mental retardation syndrome X-linked, trans FXC12303M 50,000 FHC ,000 BACH1 BTB and CNC homology 1, basic leucine zipper transcription fa FXC ,000 FHC ,000 BACH2 BTB and CNC homology 1, basic leucine zipper transcription fa FXC ,000 FHC ,000 BARHL1 BarH-like homeobox 1 FXC ,000 FHC ,000 BARHL2 BarH-like homeobox 2 FXC20405M 50,000 FHC ,000 BARX2 Homeobox protein BarH-like 2 FXC ,000 FHC ,000 BATF basic leucine zipper transcription factor, ATF-like FXC ,000 FHC ,000 BATF3 basic leucine zipper transcription factor, ATF-like 3 FXC ,000 FHC ,000 BCL11A B-cell CLL/lymphoma 11A (zinc finger protein) FXC ,000 FHC ,000 BCL6 B-cell CLL/lymphoma 6 FXC ,000 FHC ,000 BCL6B B-cell CLL/lymphoma 6, member B (zinc finger protein) FXC ,000 FHC ,000 BMI1 BMI1 polycomb ring finger oncogene FXC ,000 FHC ,000 BNC1 basonuclin 1 FXC04279M 50,000 FHC ,000 BRPF1 bromodomain and PHD finger containing, 1 FXC ,000 FHC ,000 BTF3 basic transcription factor 3 FXC ,000 FHC ,000 CDX1 caudal type homeobox 1 FXC ,000 FHC ,000 CDX2 caudal type homeobox 2 FXC ,000 FHC ,000 CDX4 caudal type homeobox 4 FXC27424M 50,000 FHC ,000 CEBPA CCAAT/enhancer-binding protein alpha FXC10825M 50,000 FHC ,000 CEBPB CCAAT/enhancer binding protein (C/EBP), beta FXC ,000 FHC ,000 CEBPD CCAAT/enhancer binding protein (C/EBP), delta FXC23262M 50,000 FHC ,000 CEBPE CCAAT/enhancer-binding protein epsilon (C/EBP epsilon) FXC ,000 FHC ,000 CEBPG CCAAT/enhancer binding protein (C/EBP), gamma FXC ,000 FHC ,000 CHD4 chromodomain helicase DNA binding protein 4 FXC11086M 50,000 FHC ,000 CIC capicua homolog (Drosophila) FXC ,000 FHC ,000 CLOCK clock homolog (mouse) FXC ,000 FHC ,000 CNOT4 CCR4-NOT transcription complex, subunit 4 FXC ,000 FHC ,000 CREB1 camp responsive element binding protein 1 FXC ,000 FHC ,000 CREB3 camp responsive element binding protein 3 FXC ,000 FHC ,000 CREB3L1 camp responsive element binding protein 3-like 1 FXC ,000 FHC ,000 CREB3L2 camp responsive element binding protein 3-like 2 FXC ,000 FHC ,000 CREB3L3 camp responsive element binding protein 3-like 3 FXC26402M 50,000 FHC ,000 CREB3L4 Cyclic AMP-responsive element-binding protein 3-like protein 4 FXC ,000 FHC ,000

2 CREBZF CREB/ATF bzip transcription factor FXC ,000 FHC ,000 CREM camp responsive element modulator FXC10995M 50,000 FHC ,000 CRX cone-rod homeobox FXC ,000 FHC ,000 CTCF CCCTC-binding factor (zinc finger protein) FXC ,000 FHC ,000 DDIT3 DNA damage-inducible transcript 3 (DDIT-3)(Growth arrest and FXC ,000 FHC ,000 DLX1 Homeobox protein DLX-1 FXC ,000 FHC ,000 DLX2 distal-less homeobox 2 FXC11120M 50,000 FHC ,000 DLX3 distal-less homeobox 3 FXC ,000 FHC ,000 DLX4 Homeobox protein DLX-4 (DLX-7)(DLX-8)(Beta protein 1) FXC ,000 FHC ,000 DLX5 distal-less homeobox 5 FXC ,000 FHC ,000 DMBX1 Diencephalon/mesencephalon homeobox protein 1 (Paired-like FXC ,000 FHC ,000 DPF1 D4, zinc and double PHD fingers family 1 FXC ,000 FHC ,000 DPF2 D4, zinc and double PHD fingers family 2 FXC ,000 FHC ,000 DUX1 double homeobox, 1 FXC ,000 FHC ,000 DUX3 double homeobox, 3 FXC ,000 FHC ,000 EBF1 Transcription factor COE1 (O/E-1)(OE-1)(Early B-cell factor) FXC ,000 FHC ,000 EBF2 early B-cell factor 2 FXC ,000 FHC ,000 EBF4 early B-cell factor 4 FXC ,000 FHC ,000 EGR1 early growth response 1 FXC31400M 50,000 FHC ,000 EGR2 Early growth response protein 2 FXC ,000 FHC ,000 EGR3 early growth response 3 FXC ,000 FHC ,000 EGR4 early growth response 4 FXC ,000 FHC ,000 EHF ets homologous factor FXC24200M 50,000 FHC ,000 ELF1 ETS-related transcription factor Elf-1 (E74-like factor 1) FXC ,000 FHC ,000 ELF3 ETS-related transcription factor Elf-3 (E74-like factor 3)(Epithel FXC ,000 FHC ,000 ELF4 ETS-related transcription factor Elf-4 (E74-like factor 4)(Myeloid FXC ,000 FHC ,000 ELF5 ETS-related transcription factor Elf-5 (E74-like factor 5)(Epithel FXC ,000 FHC ,000 ELK1 ELK1, member of ETS oncogene family FXC ,000 FHC ,000 ELK3 ELK3, ETS-domain protein (SRF accessory protein 2) FXC ,000 FHC ,000 ELK4 ELK4, ETS-domain protein (SRF accessory protein 1), transcrip FXC20788M 50,000 FHC ,000 EMX1 empty spiracles homeobox 1 FXC ,000 FHC ,000 EMX2 empty spiracles homeobox 2 FXC ,000 FHC ,000 EN1 engrailed homeobox 1 FXC04893M 50,000 FHC ,000 EPAS1 endothelial PAS domain protein 1 FXC ,000 FHC ,000 ERF Ets2 repressor factor FXC ,000 FHC ,000 ERG v-ets erythroblastosis virus E26 oncogene homolog (avian) FXC ,000 FHC ,000 ESR1 Estrogen receptor (ER)(Estradiol receptor)(er-alpha)(nuclear r FXC ,000 FHC ,000 ESR2 estrogen receptor 2 (ER beta) FXC12655M 50,000 FHC ,000 ESRRA estrogen-related receptor alpha FXC ,000 FHC ,000 ESRRB estrogen-related receptor beta FXC ,000 FHC ,000 ESRRG estrogen-related receptor gamma FXC ,000 FHC ,000 ETS1 v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) FXC ,000 FHC ,000 ETS2 Protein C-ets-2 FXC ,000 FHC ,000 ETV1 ets variant 1 FXC ,000 FHC ,000 ETV2 ets variant 2 FXC ,000 FHC ,000 ETV3 ETS translocation variant 3 (ETS domain transcriptional repres FXC ,000 FHC ,000 ETV4 ets variant 4 FXC ,000 FHC ,000 ETV5 ets variant 5 FXC ,000 FHC ,000 ETV6 ets variant 6 FXC ,000 FHC ,000 ETV7 ets variant 7 FXC ,000 FHC ,000 EVX1 even-skipped homeobox 1 FXC22886M 50,000 FHC ,000 FIZ1 FLT3-interacting zinc finger 1 FXC31590M 50,000 FHC ,000 FLI1 Friend leukemia virus integration 1 FXC ,000 FHC ,000 FOS v-fos FBJ murine osteosarcoma viral oncogene homolog FXC ,000 FHC ,000 FOSB FBJ murine osteosarcoma viral oncogene homolog B FXC ,000 FHC ,000 FOSL1 FOS-like antigen 1 FXC ,000 FHC ,000 FOSL2 Fos-related antigen 2 FXC ,000 FHC ,000 FOXA1 forkhead box A1 FXC ,000 FHC ,000 FOXA2 forkhead box A2 FXC ,000 FHC ,000

3 FOXA3 forkhead box A3 FXC ,000 FHC ,000 FOXB1 forkhead box B1 FXC ,000 FHC ,000 FOXC2 forkhead box C2 (MFH-1, mesenchyme forkhead 1) FXC05223M 50,000 FHC ,000 FOXD3 forkhead box D3 FXC ,000 FHC ,000 FOXD4 forkhead box D4 FXC ,000 FHC ,000 FOXE1 forkhead box E1 (thyroid transcription factor 2) FXC ,000 FHC ,000 FOXF1 forkhead box F1 FXC ,000 FHC ,000 FOXF2 forkhead box F2 FXC ,000 FHC ,000 FOXH1 forkhead box H1 FXC ,000 FHC ,000 FOXI1 forkhead box I1 FXC ,000 FHC ,000 FOXJ1 forkhead box J1 FXC ,000 FHC ,000 FOXJ2 forkhead box J2 FXC ,000 FHC ,000 FOXJ3 forkhead box J3 FXC ,000 FHC ,000 FOXL1 forkhead box L1 FXC ,000 FHC ,000 FOXM1 Forkhead box protein M1 (Forkhead-related protein FKHL16)(H FXC ,000 FHC ,000 FOXN1 forkhead box N1 FXC05225M 50,000 FHC ,000 FOXN2 Forkhead box protein N2 (Human T-cell leukemia virus enhanc FXC ,000 FHC ,000 FOXN3 Forkhead box protein N3 (Checkpoint suppressor 1) FXC ,000 FHC ,000 FOXN4 forkhead box N4 FXC ,000 FHC ,000 FOXO3 forkhead box O3 FXC22719M 50,000 FHC ,000 FOXO4 forkhead box O4 FXC ,000 FHC ,000 FOXP1 Forkhead box protein P1 FXC ,000 FHC ,000 FOXP3 forkhead box P3 FXC ,000 FHC ,000 FOXP4 Forkhead box protein P4 (Fork head-related protein-like A) FXC ,000 FHC ,000 GABPA GA binding protein transcription factor, alpha subunit 60kDa FXC ,000 FHC ,000 GBX2 gastrulation brain homeobox 2 FXC ,000 FHC ,000 GFI1 growth factor independent 1 transcription repressor FXC ,000 FHC ,000 GFI1B Zinc finger protein Gfi-1b (Growth factor independent protein 1B FXC ,000 FHC ,000 GLI1 GLI family zinc finger 1 FXC ,000 FHC ,000 GLI2 GLI family zinc finger 2 FXC ,000 FHC ,000 GLI3 GLI family zinc finger 3 FXC ,000 FHC ,000 GLI4 Zinc finger protein 41 homolog (Zfp-41) FXC08726M 50,000 FHC ,000 GLIS1 GLIS family zinc finger 1 FXC20314M 50,000 FHC ,000 GLIS2 GLIS family zinc finger 2 FXC ,000 FHC ,000 GSC Homeobox protein goosecoid FXC ,000 FHC ,000 GSX1 GS homeobox 1 FXC ,000 FHC ,000 GSX2 GS homeobox 2 FXC ,000 FHC ,000 GTF2A1 Transcription initiation factor IIA subunit 1 (General transcriptio FXC ,000 FHC ,000 GTF2A1L general transcription factor IIA, 1-like FXC11049M 50,000 FHC ,000 GTF2A2 general transcription factor IIA, 2, 12kDa FXC ,000 FHC ,000 GTF2B Transcription initiation factor IIB (General transcription factor TF FXC ,000 FHC ,000 GTF2E1 general transcription factor IIE, polypeptide 1, alpha 56kDa FXC ,000 FHC ,000 GTF2E2 general transcription factor IIE, polypeptide 2, beta 34kDa FXC ,000 FHC ,000 GTF2F1 general transcription factor IIF, polypeptide 1, 74kDa FXC ,000 FHC ,000 GTF2F2 General transcription factor IIF subunit 2 (EC )(Transcrip FXC ,000 FHC ,000 GTF2H1 general transcription factor IIH, polypeptide 1, 62kDa FXC ,000 FHC ,000 GTF2H2 general transcription factor IIH, polypeptide 2, 44kDa FXC ,000 FHC ,000 GTF2H3 general transcription factor IIH, polypeptide 3, 34kDa FXC ,000 FHC ,000 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa FXC09855M 50,000 FHC ,000 GTF2I general transcription factor II, i FXC ,000 FHC ,000 GTF2IRD1 General transcription factor II-I repeat domain-containing protei FXC ,000 FHC ,000 GTF2IRD2 General transcription factor II-I repeat domain-containing protei FXC ,000 FHC ,000 GTF3A general transcription factor IIIA FXC10865M 50,000 FHC ,000 GTF3C1 general transcription factor IIIC, polypeptide 1, alpha 220kDa FXC28375M 50,000 FHC ,000 GTF3C2 general transcription factor IIIC, polypeptide 2, beta 110kDa FXC ,000 FHC ,000 GTF3C3 general transcription factor IIIC, polypeptide 3, 102kDa FXC ,000 FHC ,000 GTF3C4 General transcription factor 3C polypeptide 4 (EC )(Tra FXC ,000 FHC ,000 GTF3C5 general transcription factor IIIC, polypeptide 5, 63kDa FXC08546M 50,000 FHC ,000 GZF1 GDNF-inducible zinc finger protein 1 FXC ,000 FHC ,000

4 HAND1 heart and neural crest derivatives expressed 1 FXC ,000 FHC ,000 HAND2 heart and neural crest derivatives expressed 2 FXC ,000 FHC ,000 HES1 Transcription factor HES-1 (Hairy and enhancer of split 1)(Hairy FXC ,000 FHC ,000 HES2 hairy and enhancer of split 2 (Drosophila) FXC ,000 FHC ,000 HES6 hairy and enhancer of split 6 (Drosophila) FXC ,000 FHC ,000 HES7 hairy and enhancer of split 7 (Drosophila) FXC ,000 FHC ,000 HESX1 Homeobox expressed in ES cells 1 (Homeobox protein ANF)(h FXC ,000 FHC ,000 HEY1 hairy/enhancer-of-split related with YRPW motif 1 FXC ,000 FHC ,000 HEY2 hairy/enhancer-of-split related with YRPW motif 2 FXC ,000 FHC ,000 HEYL hairy/enhancer-of-split related with YRPW motif-like FXC ,000 FHC ,000 HHEX Hematopoietically-expressed homeobox protein HHEX (Homeo FXC ,000 FHC ,000 HIC1 hypermethylated in cancer 1 FXC11001M 50,000 FHC ,000 HIC2 hypermethylated in cancer 2 FXC ,000 FHC ,000 HIF1A hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix FXC ,000 FHC ,000 HIF3A Hypoxia-inducible factor 3 alpha (HIF-3 alpha)(hif3 alpha 1)(M FXC ,000 FHC ,000 HIVEP1 human immunodeficiency virus type I enhancer binding protein FXC ,000 FHC ,000 HIVEP2 human immunodeficiency virus type I enhancer binding protein FXC ,000 FHC ,000 HIVEP3 human immunodeficiency virus type I enhancer binding protein FXC ,000 FHC ,000 HLF Hepatic leukemia factor FXC ,000 FHC ,000 HLTF helicase-like transcription factor FXC28939M 50,000 FHC ,000 HLX H2.0-like homeobox FXC ,000 FHC ,000 HMG20A high-mobility group 20A FXC ,000 FHC ,000 HMG20B high mobility group 20B FXC30780M 50,000 FHC ,000 HMGB1 High mobility group protein B1 (High mobility group protein 1)(H FXC ,000 FHC ,000 HMGB2 high-mobility group box 2 FXC ,000 FHC ,000 HMX2 H6 family homeobox 2 FXC27892M 50,000 FHC ,000 HNF1A Hepatocyte nuclear factor 1-alpha (HNF-1A)(Liver-specific tran FXC ,000 FHC ,000 HNF1B Hepatocyte nuclear factor 1-beta (HNF-1-beta)(HNF-1B)(Trans FXC ,000 FHC ,000 HNF4A hepatocyte nuclear factor 4, alpha FXC ,000 FHC ,000 HNF4G hepatocyte nuclear factor 4, gamma FXC23316M 50,000 FHC ,000 HOXA1 homeobox A1 FXC ,000 FHC ,000 HOXA10 homeobox A10 FXC ,000 FHC ,000 HOXA11 homeobox A11 FXC ,000 FHC ,000 HOXA2 homeobox A2 FXC ,000 FHC ,000 HOXA3 homeobox A3 FXC ,000 FHC ,000 HOXA4 homeobox A4 FXC ,000 FHC ,000 HOXA5 Homeobox protein Hox-A5 (Hox-1C) FXC ,000 FHC ,000 HOXA6 Homeobox protein Hox-A6 (Hox-1B) FXC ,000 FHC ,000 HOXA7 homeobox A7 FXC ,000 FHC ,000 HOXA9 homeobox A9 FXC ,000 FHC ,000 HOXB13 homeobox B13 FXC ,000 FHC ,000 HOXB2 homeobox B2 FXC26088M 50,000 FHC ,000 HOXB3 homeobox B3 FXC ,000 FHC ,000 HOXB4 homeobox B4 FXC26089M 50,000 FHC ,000 HOXB5 homeobox B5 FXC ,000 FHC ,000 HOXB6 homeobox B6 FXC ,000 FHC ,000 HOXB8 homeobox B8 FXC ,000 FHC ,000 HOXB9 homeobox B9 FXC ,000 FHC ,000 HOXC10 homeobox C10 FXC ,000 FHC ,000 HOXC11 homeobox C11 FXC24755M 50,000 FHC ,000 HOXC12 homeobox C12 FXC ,000 FHC ,000 HOXC4 homeobox C4 FXC ,000 FHC ,000 HOXC5 homeobox C5 FXC ,000 FHC ,000 HOXC6 Homeobox protein Hox-C6 (Hox-3C)(HHO.C8)(CP25) FXC ,000 FHC ,000 HOXC8 homeobox C8 FXC ,000 FHC ,000 HOXC9 homeobox C9 FXC ,000 FHC ,000 HOXD1 homeobox D1 FXC ,000 FHC ,000 HOXD10 homeobox D10 FXC ,000 FHC ,000 HOXD13 homeobox D13 FXC ,000 FHC ,000

5 HOXD3 homeobox D3 FXC ,000 FHC ,000 HOXD4 homeobox D4 FXC ,000 FHC ,000 HOXD8 homeobox D8 FXC ,000 FHC ,000 HOXD9 homeobox D9 FXC ,000 FHC ,000 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix p FXC ,000 FHC ,000 ID2 inhibitor of DNA binding 2, dominant negative helix-loop-helix p FXC ,000 FHC ,000 ID3 inhibitor of DNA binding 3, dominant negative helix-loop-helix p FXC ,000 FHC ,000 IKZF1 IKAROS family zinc finger 1 (Ikaros) FXC ,000 FHC ,000 IKZF2 Zinc finger protein Helios (Ikaros family zinc finger protein 2) FXC ,000 FHC ,000 IKZF3 IKAROS family zinc finger 3 (Aiolos) FXC25999M 50,000 FHC ,000 IKZF4 IKAROS family zinc finger 4 (Eos) FXC ,000 FHC ,000 IKZF5 IKAROS family zinc finger 5 (Pegasus) FXC ,000 FHC ,000 IRX4 Iroquois-class homeodomain protein IRX-4 (Iroquois homeobox FXC ,000 FHC ,000 IRX5 iroquois homeobox 5, transcript variant 1 FXC25701M 50,000 FHC ,000 IRX6 iroquois homeobox 6 FXC ,000 FHC ,000 ISL1 ISL LIM homeobox 1 FXC ,000 FHC ,000 JDP2 Jun dimerization protein 2 FXC ,000 FHC ,000 JMJD4 jumonji domain containing 4 FXC ,000 FHC07769M 60,000 JUN jun oncogene FXC ,000 FHC ,000 JUNB jun B proto-oncogene FXC ,000 FHC ,000 JUND jun D proto-oncogene FXC ,000 FHC ,000 KLF1 Kruppel-like factor 1 (erythroid) FXC ,000 FHC ,000 KLF10 Kruppel-like factor 10 FXC ,000 FHC ,000 KLF11 Kruppel-like factor 11 FXC ,000 FHC ,000 KLF12 Kruppel-like factor 12 FXC ,000 FHC ,000 KLF15 Kruppel-like factor 15 FXC ,000 FHC ,000 KLF16 Kruppel-like factor 16 FXC26377M 50,000 FHC ,000 KLF3 Kruppel-like factor 3 (basic) FXC ,000 FHC ,000 KLF4 Kruppel-like factor 4 (gut) FXC ,000 FHC ,000 KLF5 Kruppel-like factor 5 (intestinal) FXC09924M 50,000 FHC ,000 KLF6 Krueppel-like factor 6 (Core promoter element-binding protein)( FXC ,000 FHC ,000 KLF7 Kruppel-like factor 7 (ubiquitous) FXC ,000 FHC ,000 KLF8 Kruppel-like factor 8 FXC ,000 FHC ,000 KLF9 Kruppel-like factor 9 FXC ,000 FHC ,000 KLHL28 kelch-like 28 (Drosophila) FXC11370M 50,000 FHC ,000 LEF1 lymphoid enhancer-binding factor 1 FXC ,000 FHC ,000 LHX1 LIM homeobox 1 FXC ,000 FHC ,000 LHX2 LIM/homeobox protein Lhx2 (LIM homeobox protein 2)(Homeob FXC ,000 FHC ,000 LHX3 LIM homeobox 3 FXC23708M 50,000 FHC ,000 LHX4 LIM homeobox 4 FXC ,000 FHC ,000 LHX5 LIM homeobox 5 FXC ,000 FHC ,000 LHX8 LIM homeobox 8 FXC27665M 50,000 FHC ,000 LHX9 LIM homeobox 9, transcript variant 1 FXC20752M 50,000 FHC ,000 LMX1A LIM homeobox transcription factor 1, alpha FXC ,000 FHC ,000 LMX1B LIM homeobox transcription factor 1-beta (LIM/homeobox prote FXC ,000 FHC ,000 LYL1 lymphoblastic leukemia derived sequence 1 FXC ,000 FHC ,000 MAFB v-maf musculoaponeurotic fibrosarcoma oncogene homolog B FXC ,000 FHC ,000 MAFF v-maf musculoaponeurotic fibrosarcoma oncogene homolog F FXC27251M 50,000 FHC ,000 MAFG v-maf musculoaponeurotic fibrosarcoma oncogene homolog G FXC ,000 FHC ,000 MAFK v-maf musculoaponeurotic fibrosarcoma oncogene homolog K FXC ,000 FHC ,000 MAX MYC associated factor X FXC ,000 FHC ,000 MAZ MYC-associated zinc finger protein (purine-binding transcription FXC10828M 50,000 FHC ,000 MEIS1 Homeobox protein Meis1 FXC ,000 FHC ,000 MEIS2 Meis homeobox 2 FXC ,000 FHC ,000 MEIS3 Meis homeobox 3 FXC ,000 FHC ,000 MEIS3 Meis homeobox 3 FXC ,000 FHC ,000 MEOX1 Homeobox protein MOX-1 (Mesenchyme homeobox 1) FXC ,000 FHC ,000 MEOX2 mesenchyme homeobox 2 FXC ,000 FHC ,000 MESP1 mesoderm posterior 1 homolog (mouse) FXC25503M 50,000 FHC ,000

6 MESP2 mesoderm posterior 2 homolog (mouse) FXC11542M 50,000 FHC ,000 MID1 midline 1 (Opitz/BBB syndrome) FXC ,000 FHC ,000 MITF Microphthalmia-associated transcription factor FXC ,000 FHC ,000 MLX Max-like protein X (Max-like bhlhzip protein)(bigmax protein)( FXC ,000 FHC ,000 MLXIPL Williams-Beuren syndrome chromosomal region 14 protein (W FXC ,000 FHC ,000 MNAT1 menage a trois homolog 1, cyclin H assembly factor (Xenopus FXC ,000 FHC ,000 MNT MAX binding protein FXC ,000 FHC ,000 MSC musculin (activated B-cell factor-1) FXC ,000 FHC ,000 MSX1 msh homeobox 1 FXC ,000 FHC ,000 MSX2 msh homeobox 2 FXC08787M 50,000 FHC ,000 MXD1 MAX dimerization protein 1 FXC ,000 FHC ,000 MXD4 MAX dimerization protein 4 FXC ,000 FHC ,000 MXI1 MAX interactor 1 FXC ,000 FHC ,000 MYC v-myc myelocytomatosis viral oncogene homolog (avian) FXC ,000 FHC ,000 MYC Myc proto-oncogene protein (c-myc)(transcription factor p64) FXC ,000 FHC ,000 MYC Myc proto-oncogene protein (c-myc)(transcription factor p64) FXC ,000 FHC ,000 MYCL1 L-myc-1 proto-oncogene protein FXC ,000 FHC ,000 MYCN v-myc myelocytomatosis viral related oncogene, neuroblastom FXC ,000 FHC ,000 MYF5 myogenic factor 5 FXC ,000 FHC ,000 MYF6 Myogenic factor 6 (Myf-6) FXC ,000 FHC ,000 MYNN myoneurin FXC ,000 FHC ,000 MYOD1 myogenic differentiation 1 FXC ,000 FHC ,000 MYOG myogenin (myogenic factor 4) FXC ,000 FHC ,000 NANOG Homeobox protein NANOG FXC12077M 50,000 FHC ,000 NCOA2 nuclear receptor coactivator 2 FXC ,000 FHC ,000 NCOA3 nuclear receptor coactivator 3 FXC ,000 FHC ,000 NEUROD1 neurogenic differentiation 1 FXC ,000 FHC ,000 NEUROD2 neurogenic differentiation 2 FXC ,000 FHC ,000 NEUROD4 Neurogenic differentiation factor 4 (NeuroD4)(Protein atonal ho FXC ,000 FHC ,000 NEUROD6 neurogenic differentiation 6 FXC ,000 FHC ,000 NEUROG1 neurogenin 1 FXC ,000 FHC ,000 NEUROG2 neurogenin 2 FXC ,000 FHC ,000 NEUROG3 neurogenin 3 FXC ,000 FHC ,000 NFE2 nuclear factor (erythroid-derived 2), 45kDa FXC ,000 FHC ,000 NFE2L1 nuclear factor (erythroid-derived 2)-like 1 FXC ,000 FHC ,000 NFE2L2 nuclear factor (erythroid-derived 2)-like 2 FXC ,000 FHC ,000 NFE2L3 nuclear factor (erythroid-derived 2)-like 3 FXC22882M 50,000 FHC ,000 NFIL3 nuclear factor, interleukin 3 regulated FXC ,000 FHC ,000 NFX1 nuclear transcription factor, X-box binding 1 FXC ,000 FHC ,000 NHLH1 nescient helix loop helix 1 FXC ,000 FHC ,000 NHLH2 Helix-loop-helix protein 2 (HEN2)(Nescient helix loop helix 2)(N FXC ,000 FHC ,000 NKX2-1 NK2 homeobox 1 FXC10939M 50,000 FHC ,000 NKX2-2 NK2 homeobox 2 FXC ,000 FHC ,000 NKX2-3 Homeobox protein Nkx-2.3 FXC11568M 50,000 FHC ,000 NKX2-5 NK2 transcription factor related, locus 5 (Drosophila) FXC ,000 FHC ,000 NKX3-1 NK3 homeobox 1 FXC ,000 FHC ,000 NKX3-2 NK3 homeobox 2 FXC ,000 FHC ,000 NKX6-2 NK6 homeobox 2 FXC24074M 50,000 FHC ,000 NKX6-3 Homeobox protein Nkx-6.3 FXC ,000 FHC ,000 NOBOX NOBOX oogenesis homeobox FXC ,000 FHC ,000 NPAS1 neuronal PAS domain protein 1 FXC26706M 50,000 FHC ,000 NPAS3 neuronal PAS domain protein 3 FXC ,000 FHC ,000 NR0B1 nuclear receptor subfamily 0, group B, member 1 FXC ,000 FHC ,000 NR0B2 nuclear receptor subfamily 0, group B, member 2 FXC20160M 50,000 FHC ,000 NR1D1 nuclear receptor subfamily 1, group D, member 1 FXC ,000 FHC ,000 NR1D2 nuclear receptor subfamily 1, group D, member 2 FXC ,000 FHC ,000 NR1H2 nuclear receptor subfamily 1, group H, member 2 FXC ,000 FHC ,000 NR1H3 nuclear receptor subfamily 1, group H, member 3 FXC ,000 FHC ,000 NR1H4 nuclear receptor subfamily 1, group H, member 4 FXC ,000 FHC ,000

7 NR1I2 Nuclear receptor subfamily 1 group I member 2 (Orphan nuclea FXC ,000 FHC ,000 NR1I2 nuclear receptor subfamily 1, group I, member 2, transcript var FXC31716M 50,000 FHC ,000 NR1I3 nuclear receptor subfamily 1, group I, member 3 FXC20672M 50,000 FHC ,000 NR2C1 nuclear receptor subfamily 2, group C, member 1 FXC24833M 50,000 FHC ,000 NR2C2 nuclear receptor subfamily 2, group C, member 2 FXC ,000 FHC ,000 NR2E1 nuclear receptor subfamily 2, group E, member 1 FXC ,000 FHC ,000 NR2E3 nuclear receptor subfamily 2, group E, member 3 FXC11121M 50,000 FHC ,000 NR2F1 nuclear receptor subfamily 2, group F, member 1 FXC ,000 FHC ,000 NR2F2 nuclear receptor subfamily 2, group F, member 2 FXC10946M 50,000 FHC ,000 NR2F6 nuclear receptor subfamily 2, group F, member 6 FXC ,000 FHC ,000 NR3C1 nuclear receptor subfamily 3, group C, member 1 (glucocortico FXC ,000 FHC ,000 NR3C2 nuclear receptor subfamily 3, group C, member 2 FXC ,000 FHC ,000 NR4A1 nuclear receptor subfamily 4, group A, member 1 FXC ,000 FHC ,000 NR4A1 nuclear receptor subfamily 4, group A, member 1 FXC08830M 50,000 FHC ,000 NR4A2 nuclear receptor subfamily 4, group A, member 2 FXC21198M 50,000 FHC ,000 NR4A3 nuclear receptor subfamily 4, group A, member 3 FXC ,000 FHC ,000 NR5A1 nuclear receptor subfamily 5, group A, member 1 FXC ,000 FHC ,000 NR5A2 nuclear receptor subfamily 5, group A, member 2 FXC11953M 50,000 FHC ,000 NR6A1 nuclear receptor subfamily 6, group A, member 1 FXC12632M 50,000 FHC ,000 NRL neural retina leucine zipper FXC ,000 FHC ,000 OLIG1 oligodendrocyte transcription factor 1 FXC ,000 FHC ,000 OLIG3 oligodendrocyte transcription factor 3 FXC ,000 FHC ,000 ONECUT1 one cut homeobox 1 FXC ,000 FHC ,000 OSR1 odd-skipped related 1 (Drosophila) FXC10938M 50,000 FHC ,000 OTP Homeobox protein orthopedia FXC ,000 FHC ,000 OTX1 Homeobox protein OTX1 (Orthodenticle homolog 1) FXC ,000 FHC ,000 OTX2 orthodenticle homeobox 2 FXC ,000 FHC ,000 OVOL1 ovo-like 1(Drosophila) FXC ,000 FHC ,000 OVOL2 ovo-like 2 (Drosophila) FXC ,000 FHC ,000 PATZ1 POZ (BTB) and AT hook containing zinc finger 1 FXC ,000 FHC ,000 PAX3 paired box 3, transcript variant PA FXC21332M 50,000 FHC ,000 PAX4 paired box 4 FXC ,000 FHC ,000 PAX6 Paired box protein Pax-6 (Oculorhombin)(Aniridia type II protein FXC ,000 FHC ,000 PAX7 paired box 7, transcript variant 2 FXC20120M 50,000 FHC ,000 PBX1 pre-b-cell leukemia homeobox 1 FXC ,000 FHC ,000 PBX2 Pre-B-cell leukemia transcription factor 2 FXC ,000 FHC ,000 PBX3 pre-b-cell leukemia homeobox 3 FXC ,000 FHC ,000 PCGF2 polycomb group ring finger 2 FXC ,000 FHC ,000 PCGF3 polycomb group ring finger 3 FXC21835M 50,000 FHC ,000 PDX1 pancreatic and duodenal homeobox 1 FXC ,000 FHC ,000 PGR progesterone receptor FXC ,000 FHC ,000 PHF21A PHD finger protein 21A FXC ,000 FHC ,000 PITX1 paired-like homeodomain 1 FXC ,000 FHC ,000 PITX2 Pituitary homeobox 2 (Paired-like homeodomain transcription fa FXC ,000 FHC ,000 PITX3 paired-like homeodomain 3 FXC ,000 FHC ,000 PKNOX1 PBX/knotted 1 homeobox 1 FXC ,000 FHC ,000 PKNOX2 PBX/knotted 1 homeobox 2 FXC ,000 FHC ,000 PLAG1 pleiomorphic adenoma gene 1 FXC ,000 FHC ,000 PLAGL1 pleiomorphic adenoma gene-like 1 FXC ,000 FHC ,000 PLAGL2 pleiomorphic adenoma gene-like 2 FXC ,000 FHC ,000 PML promyelocytic leukemia FXC ,000 FHC ,000 POU1F1 Pituitary-specific positive transcription factor 1 (Pit-1)(Growth h FXC ,000 FHC ,000 POU2F1 POU class 2 homeobox 1 FXC ,000 FHC ,000 POU2F2 POU class 2 homeobox 2 FXC28631M 40,000 FHC ,000 POU2F3 POU class 2 homeobox 3 FXC24501M 50,000 FHC ,000 POU3F2 POU class 3 homeobox 2 FXC ,000 FHC ,000 POU3F4 POU class 3 homeobox 4 FXC ,000 FHC ,000 POU4F3 POU class 4 homeobox 3 FXC ,000 FHC ,000 POU6F1 POU class 6 homeobox 1 FXC28134M 50,000 FHC ,000

8 POU6F2 POU class 6 homeobox 2 FXC ,000 FHC ,000 PPARA peroxisome proliferator-activated receptor alpha FXC ,000 FHC ,000 PPARD peroxisome proliferator-activated receptor delta FXC ,000 FHC ,000 PPARG peroxisome proliferator-activated receptor gamma FXC ,000 FHC ,000 PRDM1 PR domain zinc finger protein 1 (PR domain-containing protein FXC ,000 FHC ,000 PRDM10 PR domain containing 10 FXC ,000 FHC ,000 PRDM16 PR domain containing 16 FXC ,000 FHC ,000 PRDM4 PR domain containing 4 FXC ,000 FHC ,000 PRDM5 PR domain containing 5 FXC ,000 FHC ,000 PRDM8 PR domain containing 8 FXC ,000 FHC ,000 PROP1 PROP paired-like homeobox 1 FXC ,000 FHC ,000 PRRX1 Paired mesoderm homeobox protein 1 (Paired-related homeob FXC ,000 FHC ,000 PTF1A pancreas specific transcription factor, 1a FXC ,000 FHC ,000 RARA retinoic acid receptor, alpha FXC09936M 50,000 FHC ,000 RARB retinoic acid receptor, beta FXC21460M 50,000 FHC ,000 RARG Retinoic acid receptor gamma (RAR-gamma)(Nuclear receptor FXC ,000 FHC ,000 RBAK RB-associated KRAB zinc finger FXC ,000 FHC ,000 REPIN1 replication initiator 1 FXC ,000 FHC ,000 REST RE1-silencing transcription factor FXC ,000 FHC ,000 RFPL3 ret finger protein-like 3 FXC ,000 FHC ,000 RHOXF1 Rhox homeobox family, member 1 FXC ,000 FHC ,000 RING1 ring finger protein 1 FXC ,000 FHC ,000 RNF10 ring finger protein 10 FXC ,000 FHC ,000 RNF103 ring finger protein 103 FXC28714M 50,000 FHC ,000 RNF112 ring finger protein 112 FXC07443M 50,000 FHC ,000 RNF113A ring finger protein 113A FXC ,000 FHC ,000 RNF113B ring finger protein 113B FXC ,000 FHC ,000 RNF114 RING finger protein 114 (Zinc finger protein 313) FXC ,000 FHC ,000 RNF115 ring finger protein 115 FXC20515M 50,000 FHC ,000 RNF13 RING finger protein 13 FXC ,000 FHC ,000 RNF135 ring finger protein 135, transcript variant 1 FXC25954M 50,000 FHC ,000 RNF14 ring finger protein 14 FXC ,000 FHC ,000 RNF141 RING finger protein 141 (Zinc finger protein 230) FXC ,000 FHC ,000 RNF144A ring finger protein 144A FXC ,000 FHC ,000 RNF2 ring finger protein 2 FXC ,000 FHC ,000 RNF24 RING finger protein 24 FXC ,000 FHC ,000 RNF4 ring finger protein 4 FXC ,000 FHC ,000 RNF8 ring finger protein 8 FXC ,000 FHC ,000 RORB RAR-related orphan receptor B FXC23532M 50,000 FHC ,000 RORC RAR-related orphan receptor C FXC09376M 50,000 FHC ,000 RXRA retinoid X receptor, alpha FXC ,000 FHC ,000 RXRB retinoid X receptor, beta FXC ,000 FHC ,000 RXRG Retinoic acid receptor RXR-gamma (Retinoid X receptor gamm FXC ,000 FHC ,000 SALL2 sal-like 2 (Drosophila) FXC ,000 FHC ,000 SATB1 SATB homeobox 1 FXC ,000 FHC ,000 SATB1 DNA-binding protein SATB1 (Special AT-rich sequence-binding FXC ,000 FHC ,000 SATB2 SATB homeobox 2 FXC ,000 FHC ,000 SCRT1 scratch homolog 1, zinc finger protein (Drosophila) FXC ,000 FHC ,000 SHOX2 short stature homeobox 2, transcript variant 2 FXC28943M 50,000 FHC ,000 SIAH1 seven in absentia homolog 1 (Drosophila) FXC ,000 FHC ,000 SIAH2 seven in absentia homolog 2 (Drosophila) FXC21731M 50,000 FHC ,000 SIM1 single-minded homolog 1 (Drosophila) FXC06829M 50,000 FHC ,000 SIX1 SIX homeobox 1 FXC25194M 50,000 FHC ,000 SIX2 SIX homeobox 2 FXC ,000 FHC ,000 SIX3 SIX homeobox 3 FXC ,000 FHC ,000 SIX5 sine oculis homeobox homolog 5 (Drosophila) FXC ,000 FHC ,000 SIX6 SIX homeobox 6 FXC25193M 50,000 FHC ,000 SMARCE1 SWI/SNF related, matrix associated, actin dependent regulator FXC ,000 FHC ,000 SNAI1 snail homolog 1 (Drosophila) FXC ,000 FHC ,000

9 SNAI2 snail homolog 2 (Drosophila) FXC ,000 FHC ,000 SNAI3 snail homolog 3 (Drosophila) FXC ,000 FHC ,000 SOX10 SRY (sex determining region Y)-box 10 FXC ,000 FHC ,000 SOX11 SRY (sex determining region Y)-box 11 FXC ,000 FHC ,000 SOX12 SRY (sex determining region Y)-box 12 FXC26859M 50,000 FHC ,000 SOX13 Transcription factor SOX-13 (Type 1 diabetes autoantigen ICA1 FXC ,000 FHC ,000 SOX14 SRY (sex determining region Y)-box 14 FXC ,000 FHC ,000 SOX15 SRY (sex determining region Y)-box 15 FXC07936M 50,000 FHC ,000 SOX17 SRY (sex determining region Y)-box 17 FXC ,000 FHC ,000 SOX2 SRY (sex determining region Y)-box 2 FXC ,000 FHC ,000 SOX21 SRY (sex determining region Y)-box 21 FXC ,000 FHC ,000 SOX30 Transcription factor SOX-30 FXC ,000 FHC ,000 SOX4 SRY (sex determining region Y)-box 4 FXC ,000 FHC ,000 SOX6 SRY (sex determining region Y)-box 6 FXC ,000 FHC ,000 SOX7 SRY (sex determining region Y)-box 7 FXC ,000 FHC ,000 SOX8 SRY (sex determining region Y)-box 8 FXC ,000 FHC ,000 SOX9 SRY (sex determining region Y)-box 9 FXC ,000 FHC ,000 SP3 Transcription factor Sp3 FXC ,000 FHC ,000 SP4 Sp4 transcription factor FXC31424M 50,000 FHC ,000 SP6 Sp6 transcription factor FXC ,000 FHC ,000 SP7 Transcription factor Sp7 (Zinc finger protein osterix) FXC ,000 FHC ,000 SPDEF SAM pointed domain-containing Ets transcription factor (Prosta FXC ,000 FHC ,000 SPEN spen homolog, transcriptional regulator (Drosophila) FXC ,000 FHC00149M 60,000 SPI1 spleen focus forming virus (SFFV) proviral integration oncogen FXC ,000 FHC ,000 SPIB Spi-B transcription factor (Spi-1/PU.1 related) FXC28657M 50,000 FHC ,000 SPIC Spi-C transcription factor (Spi-1/PU.1 related) FXC24853M 50,000 FHC ,000 SREBF1 sterol regulatory element binding transcription factor 1 FXC12086M 50,000 FHC ,000 SREBF2 sterol regulatory element binding transcription factor 2 FXC ,000 FHC ,000 SRY sex determining region Y FXC ,000 FHC ,000 SSRP1 structure specific recognition protein 1 FXC08219M 50,000 FHC ,000 TAF10 TAF10 RNA polymerase II, TATA box binding protein (TBP)-as FXC24133M 50,000 FHC ,000 TAF11 TAF11 RNA polymerase II, TATA box binding protein (TBP)-as FXC ,000 FHC ,000 TAF12 Transcription initiation factor TFIID subunit 12 (Transcription ini FXC ,000 FHC ,000 TAF13 Transcription initiation factor TFIID subunit 13 (Transcription ini FXC ,000 FHC ,000 TAF15 TAF15 RNA polymerase II, TATA box binding protein (TBP)-as FXC28459M 40,000 FHC ,000 TAF1A TATA box binding protein (TBP)-associated factor, RNA polym FXC ,000 FHC ,000 TAF1B TATA box-binding protein-associated factor RNA polymerase I FXC ,000 FHC ,000 TAF1C TATA box-binding protein-associated factor RNA polymerase I FXC ,000 FHC ,000 TAF2 TAF2 RNA polymerase II, TATA box binding protein (TBP)-ass FXC07055M 50,000 FHC ,000 TAF4B Transcription initiation factor TFIID subunit 4B (Transcription in FXC ,000 FHC ,000 TAF5 TAF5 RNA polymerase II, TATA box binding protein (TBP)-ass FXC ,000 FHC ,000 TAF5L TAF5-like RNA polymerase II, p300/cbp-associated factor (PC FXC ,000 FHC ,000 TAF6 Transcription initiation factor TFIID subunit 6 (Transcription initi FXC ,000 FHC ,000 TAF7 TAF7 RNA polymerase II, TATA box binding protein (TBP)-ass FXC ,000 FHC ,000 TAF9 transcription initiation factor TFIID subunit 9 FXC ,000 FHC ,000 TAL1 T-cell acute lymphocytic leukemia 1 FXC ,000 FHC ,000 TAL2 T-cell acute lymphocytic leukemia 2 FXC ,000 FHC ,000 TBP TATA box binding protein FXC11099M 50,000 FHC ,000 TBPL1 TBP-like 1 FXC ,000 FHC ,000 TCEAL1 transcription elongation factor A (SII)-like 1 FXC ,000 FHC ,000 TCF12 transcription factor 12 FXC ,000 FHC ,000 TCF21 transcription factor 21 FXC ,000 FHC ,000 TCF3 transcription factor 3 (E2A immunoglobulin enhancer binding fa FXC ,000 FHC ,000 TCF4 Transcription factor 4 (Immunoglobulin transcription factor 2)(IT FXC ,000 FHC ,000 TCF7L1 transcription factor 7-like 1 (T-cell specific, HMG-box) FXC21071M 50,000 FHC ,000 TEF thyrotrophic embryonic factor FXC ,000 FHC ,000 TFAM transcription factor A, mitochondrial FXC ,000 FHC ,000 TFAP4 transcription factor AP-4 (activating enhancer binding protein 4 FXC ,000 FHC ,000 TFE3 transcription factor binding to IGHM enhancer 3 FXC ,000 FHC ,000

10 TFEB Transcription factor EB FXC ,000 FHC ,000 TFEC transcription factor EC, transcript variant 1 FXC23058M 50,000 FHC ,000 TGIF1 Homeobox protein TGIF1 (5'-TG-3'-interacting factor 1) FXC ,000 FHC ,000 THRA thyroid hormone receptor, alpha (erythroblastic leukemia viral ( FXC ,000 FHC ,000 THRB thyroid hormone receptor, beta (erythroblastic leukemia viral (v FXC ,000 FHC ,000 TLX1 T-cell leukemia homeobox 1 FXC ,000 FHC ,000 TLX2 T-cell leukemia homeobox 2 FXC21058M 50,000 FHC ,000 TLX3 T-cell leukemia homeobox 3 FXC08892M 50,000 FHC ,000 TOX thymocyte selection-associated high mobility group box FXC ,000 FHC ,000 TOX3 TOX high mobility group box family member 3 FXC ,000 FHC ,000 TRERF1 transcriptional regulating factor 1 FXC ,000 FHC ,000 TRIM10 tripartite motif containing 10, transcript variant 1 FXC22534M 50,000 FHC ,000 TRIM13 tripartite motif-containing 13 FXC ,000 FHC ,000 TRIM15 tripartite motif-containing 15 FXC ,000 FHC ,000 TRIM21 52 kda Ro protein (Sjoegren syndrome type A antigen)(ss-a)(r FXC ,000 FHC ,000 TRIM22 tripartite motif-containing 22 FXC ,000 FHC ,000 TRIM24 tripartite motif-containing 24 FXC ,000 FHC ,000 TRIM25 tripartite motif-containing 25 FXC ,000 FHC ,000 TRIM26 tripartite motif containing 26, transcript variant 1 FXC22535M 50,000 FHC ,000 TRIM27 Zinc finger protein RFP (Ret finger protein)(tripartite motif-cont FXC ,000 FHC ,000 TRIM28 tripartite motif-containing 28 FXC ,000 FHC ,000 TRIM3 tripartite motif-containing 3 FXC ,000 FHC ,000 TRIM31 Tripartite motif-containing protein 31 FXC ,000 FHC ,000 TRIM33 tripartite motif-containing 33 FXC ,000 FHC ,000 TRIM35 tripartite motif-containing 35 FXC ,000 FHC ,000 TRIM38 Tripartite motif-containing protein 38 (RING finger protein 15)(Z FXC ,000 FHC ,000 TRIM39 Tripartite motif-containing protein 39 (RING finger protein 23)(T FXC ,000 FHC ,000 TRIM40 Tripartite motif-containing protein 40 (RING finger protein 35) FXC ,000 FHC ,000 TRIM41 tripartite motif containing 41 FXC08970M 50,000 FHC ,000 TRIM47 tripartite motif containing 47 FXC28506M 50,000 FHC ,000 TRIM5 tripartite motif containing 5 FXC27937M 50,000 FHC ,000 TRIM52 Tripartite motif-containing protein 52 (RING finger protein 102) FXC ,000 FHC ,000 TRIM56 tripartite motif containing 56 FXC30226M 50,000 FHC ,000 TRIM68 tripartite motif-containing 68 FXC ,000 FHC ,000 TRIM69 tripartite motif containing 69 FXC11977M 50,000 FHC ,000 TRIM8 tripartite motif containing 8 FXC09071M 50,000 FHC ,000 TRIM9 tripartite motif-containing 9 FXC ,000 FHC ,000 TRPS1 trichorhinophalangeal syndrome I FXC23365M 50,000 FHC ,000 TSHZ1 teashirt zinc finger homeobox 1 FXC11108M 50,000 FHC ,000 TSHZ3 teashirt zinc finger homeobox 3 FXC09675M 50,000 FHC ,000 TWIST1 twist homolog 1 FXC ,000 FHC ,000 UHRF2 ubiquitin-like, containing PHD and RING finger domains, 2 FXC ,000 FHC ,000 USF1 upstream transcription factor 1 FXC ,000 FHC ,000 USF2 upstream transcription factor 2, c-fos interacting FXC ,000 FHC ,000 VAX2 Ventral anterior homeobox 2 FXC ,000 FHC ,000 VDR Vitamin D3 receptor FXC ,000 FHC ,000 VENTX VENT homeobox homolog (Xenopus laevis) FXC ,000 FHC ,000 VEZF1 vascular endothelial zinc finger 1 FXC ,000 FHC03276M 60,000 VSX2 visual system homeobox 2 FXC25234M 50,000 FHC ,000 WHSC1 Wolf-Hirschhorn syndrome candidate 1 FXC ,000 FHC ,000 WT1 Wilms tumor 1 FXC ,000 FHC ,000 XBP1 X-box binding protein 1 FXC ,000 FHC ,000 YY1 YY1 transcription factor FXC ,000 FHC ,000 ZBTB1 zinc finger and BTB domain containing 1 FXC ,000 FHC ,000 ZBTB11 zinc finger and BTB domain containing 11 FXC11456M 50,000 FHC ,000 ZBTB16 Zinc finger and BTB domain-containing protein 16 (Zinc finger p FXC ,000 FHC ,000 ZBTB17 Zinc finger and BTB domain-containing protein 17 (Zinc finger p FXC ,000 FHC ,000 ZBTB20 zinc finger and BTB domain containing 20 FXC ,000 FHC ,000 ZBTB22 zinc finger and BTB domain containing 22 FXC ,000 FHC ,000

11 ZBTB24 zinc finger and BTB domain containing 24 FXC ,000 FHC ,000 ZBTB25 Zinc finger and BTB domain-containing protein 25 (Zinc finger p FXC ,000 FHC ,000 ZBTB26 zinc finger and BTB domain containing 26 FXC ,000 FHC ,000 ZBTB32 zinc finger and BTB domain containing 32 FXC ,000 FHC ,000 ZBTB33 zinc finger and BTB domain containing 33 FXC ,000 FHC ,000 ZBTB39 zinc finger and BTB domain containing 39 FXC ,000 FHC ,000 ZBTB4 zinc finger and BTB domain containing 4 FXC ,000 FHC ,000 ZBTB40 zinc finger and BTB domain containing 40 FXC ,000 FHC ,000 ZBTB43 zinc finger and BTB domain containing 43 FXC ,000 FHC ,000 ZBTB44 zinc finger and BTB domain containing 44 FXC ,000 FHC ,000 ZBTB45 zinc finger and BTB domain containing 45 FXC26850M 50,000 FHC ,000 ZBTB46 zinc finger and BTB domain containing 46 FXC27112M 50,000 FHC ,000 ZBTB47 zinc finger and BTB domain containing 47 FXC ,000 FHC ,000 ZBTB48 zinc finger and BTB domain containing 48 FXC08695M 50,000 FHC ,000 ZBTB6 zinc finger and BTB domain containing 6 FXC ,000 FHC ,000 ZBTB7B zinc finger and BTB domain containing 7B FXC ,000 FHC ,000 ZEB1 zinc finger E-box binding homeobox 1 FXC ,000 FHC ,000 ZEB2 zinc finger E-box binding homeobox 2 FXC ,000 FHC ,000 ZFHX2 zinc finger homeobox 2 FXC ,000 FHC00278M 60,000 ZFP1 zinc finger protein 1 homolog (mouse) FXC ,000 FHC ,000 ZFP161 zinc finger protein 161 homolog (mouse) FXC ,000 FHC ,000 ZFP2 zinc finger protein 2 homolog (mouse) FXC ,000 FHC ,000 ZFP28 zinc finger protein 28 homolog (mouse) FXC ,000 FHC ,000 ZFP3 zinc finger protein 3 homolog (mouse) FXC ,000 FHC ,000 ZFP30 zinc finger protein 30 homolog (mouse) FXC ,000 FHC ,000 ZFP42 zinc finger protein 42 homolog (mouse) FXC ,000 FHC ,000 ZFP64 Zinc finger protein 64 homolog, isoforms 3 and 4 (Zfp-64)(Zinc FXC ,000 FHC ,000 ZFP91 zinc finger protein 91 homolog (mouse) FXC28022M 50,000 FHC ,000 ZFPL1 zinc finger protein-like 1 FXC24298M 50,000 FHC ,000 ZFX zinc finger protein, X-linked FXC ,000 FHC ,000 ZHX1 zinc fingers and homeoboxes 1 FXC ,000 FHC ,000 ZHX2 zinc fingers and homeoboxes 2 FXC ,000 FHC ,000 ZHX3 zinc fingers and homeoboxes 3 FXC07426M 50,000 FHC ,000 ZIC1 Zic family member 1 (odd-paired homolog, Drosophila) FXC ,000 FHC ,000 ZIC3 Zic family member 3 (odd-paired homolog, Drosophila) FXC ,000 FHC ,000 ZKSCAN1 zinc finger with KRAB and SCAN domains 1 FXC ,000 FHC ,000 ZKSCAN4 zinc finger with KRAB and SCAN domains 4 FXC10011M 50,000 FHC ,000 ZKSCAN5 zinc finger with KRAB and SCAN domains 5 FXC11236M 50,000 FHC ,000 ZMYM4 Zinc finger MYM-type protein 4 (Zinc finger protein 262) FXC ,000 FHC11902M 60,000 ZMYND11 zinc finger, MYND domain containing 11 FXC ,000 FHC ,000 ZNF10 zinc finger protein 10 FXC ,000 FHC ,000 ZNF101 Zinc finger protein 101 (Zinc finger protein 12)(HZF12) FXC ,000 FHC ,000 ZNF107 Zinc finger protein 107 FXC ,000 FHC ,000 ZNF114 zinc finger protein 114 FXC ,000 FHC ,000 ZNF124 zinc finger protein 124 FXC ,000 FHC ,000 ZNF131 zinc finger protein 131 FXC ,000 FHC ,000 ZNF132 zinc finger protein 132 FXC11045M 50,000 FHC ,000 ZNF133 zinc finger protein 133 FXC ,000 FHC ,000 ZNF134 Zinc finger protein 134 FXC ,000 FHC ,000 ZNF135 Zinc finger protein 135 (Zinc finger protein 61)(Zinc finger prote FXC ,000 FHC ,000 ZNF136 zinc finger protein 136 FXC ,000 FHC ,000 ZNF138 zinc finger protein 138 FXC11129M 50,000 FHC ,000 ZNF138 zinc finger protein 138 FXC ,000 FHC07747M 60,000 ZNF14 zinc finger protein 14 FXC ,000 FHC ,000 ZNF140 Zinc finger protein 140 FXC ,000 FHC ,000 ZNF142 zinc finger protein 142 FXC ,000 FHC ,000 ZNF143 Zinc finger protein 143 (Selenocysteine trna gene transcriptio FXC ,000 FHC ,000 ZNF146 zinc finger protein 146 FXC ,000 FHC ,000 ZNF148 Zinc finger protein 148 (Zinc finger DNA-binding protein 89)(Tra FXC ,000 FHC ,000

12 ZNF154 zinc finger protein 154 FXC ,000 FHC ,000 ZNF155 zinc finger protein 155 FXC26675M 50,000 FHC ,000 ZNF157 Zinc finger protein 157 (Zinc finger protein 22)(HZF22) FXC ,000 FHC ,000 ZNF160 zinc finger protein 160 FXC ,000 FHC ,000 ZNF169 Zinc finger protein 169 FXC ,000 FHC ,000 ZNF17 zinc finger protein 17 FXC ,000 FHC ,000 ZNF174 Zinc finger protein 174 (AW-1)(Zinc finger and SCAN domain-c FXC ,000 FHC ,000 ZNF175 Zinc finger protein 175 (Zinc finger protein OTK18) FXC ,000 FHC ,000 ZNF177 zinc finger protein 177 FXC ,000 FHC ,000 ZNF18 zinc finger protein 18 FXC ,000 FHC ,000 ZNF182 Zinc finger protein 182 (Zinc finger protein 21)(Zinc finger prote FXC ,000 FHC ,000 ZNF184 Zinc finger protein 184 FXC ,000 FHC ,000 ZNF187 zinc finger protein 187 FXC ,000 FHC ,000 ZNF19 Zinc finger protein 19 (Zinc finger protein KOX12) FXC ,000 FHC ,000 ZNF193 Zinc finger protein 193 (PRD51)(Zinc finger and SCAN domain FXC ,000 FHC ,000 ZNF197 Zinc finger protein 197 (ZnF20)(Zinc finger protein with KRAB a FXC ,000 FHC ,000 ZNF2 zinc finger protein 2 FXC ,000 FHC ,000 ZNF200 zinc finger protein 200 FXC ,000 FHC ,000 ZNF202 zinc finger protein 202 FXC ,000 FHC ,000 ZNF205 Zinc finger protein 205 (Zinc finger protein 210) FXC ,000 FHC ,000 ZNF207 zinc finger protein 207 FXC ,000 FHC ,000 ZNF211 zinc finger protein 211, transcript variant 1 FXC26839M 50,000 FHC ,000 ZNF213 zinc finger protein 213 FXC ,000 FHC ,000 ZNF214 zinc finger protein 214 FXC ,000 FHC ,000 ZNF215 zinc finger protein 215 FXC24137M 50,000 FHC ,000 ZNF22 zinc finger protein 22 (KOX 15) FXC ,000 FHC ,000 ZNF221 Zinc finger protein 221 FXC ,000 FHC ,000 ZNF223 Zinc finger protein 223 FXC ,000 FHC ,000 ZNF224 zinc finger protein 224 FXC ,000 FHC ,000 ZNF226 zinc finger protein 226 FXC ,000 FHC ,000 ZNF232 Zinc finger protein 232 (Zinc finger and SCAN domain-containin FXC ,000 FHC ,000 ZNF238 zinc finger protein 238 FXC ,000 FHC ,000 ZNF239 zinc finger protein 239 FXC ,000 FHC ,000 ZNF24 zinc finger protein 24 FXC ,000 FHC ,000 ZNF256 zinc finger protein 256 FXC ,000 FHC ,000 ZNF263 Zinc finger protein 263 (Zinc finger protein FPM315)(Zinc finger FXC ,000 FHC ,000 ZNF264 zinc finger protein 264 FXC ,000 FHC ,000 ZNF266 zinc finger protein 266 FXC ,000 FHC ,000 ZNF268 zinc finger protein 268, transcript variant 1 FXC30561M 50,000 FHC ,000 ZNF271 zinc finger protein 271 (ZNF271), transcript variant 1, non-codin FXC ,000 FHC ,000 ZNF273 zinc finger protein 273 FXC10815M 50,000 FHC ,000 ZNF274 Zinc finger protein 274 (Zinc finger protein HFB101)(Zinc finger FXC ,000 FHC ,000 ZNF281 zinc finger protein 281 FXC ,000 FHC ,000 ZNF282 Zinc finger protein 282 (HTLV-I U5RE-binding protein 1)(HUB-1 FXC ,000 FHC ,000 ZNF286A zinc finger protein 286A FXC ,000 FHC ,000 ZNF287 zinc finger protein 287 FXC ,000 FHC ,000 ZNF295 zinc finger protein 295 FXC ,000 FHC ,000 ZNF3 zinc finger protein 3 FXC ,000 FHC ,000 ZNF30 Zinc finger protein 30 (Zinc finger protein KOX28) FXC ,000 FHC ,000 ZNF300 zinc finger protein 300 FXC ,000 FHC ,000 ZNF302 Zinc finger protein 302 (ZNF135-like)(ZNF140-like) FXC ,000 FHC ,000 ZNF304 Zinc finger protein 304 FXC ,000 FHC ,000 ZNF317 Zinc finger protein 317 FXC07457M 50,000 FHC ,000 ZNF319 zinc finger protein 319 FXC ,000 FHC ,000 ZNF32 Zinc finger protein 32 (Zinc finger protein KOX30)(C2H2-546) FXC ,000 FHC ,000 ZNF323 zinc finger protein 323 FXC ,000 FHC ,000 ZNF324 zinc finger protein 324 FXC ,000 FHC ,000 ZNF329 zinc finger protein 329 FXC ,000 FHC ,000 ZNF331 zinc finger protein 331 FXC ,000 FHC ,000

DDR2 controls the epithelial-mesenchymal-transition-related gene expression via c-myb acetylation upon matrix stiffening

DDR2 controls the epithelial-mesenchymal-transition-related gene expression via c-myb acetylation upon matrix stiffening Supplementary information controls the epithelialmesenchymaltransitionrelated gene expression via cmyb acetylation upon matrix stiffening Daehwan Kim, Eunae You, Jangho Jeong, Panseon Ko, JungWoong Kim

More information

The basic helix-loop-helix (bhlh) proteins in breast cancer progression

The basic helix-loop-helix (bhlh) proteins in breast cancer progression The basic helix-loop-helix (bhlh) proteins in breast cancer progression Kabir, Nuzhat N.; Rönnstrand, Lars; Uddin, Kazi Published in: Medical Oncology DOI: 10.1007/s12032-013-0666-9 2013 Link to publication

More information

Maturity-onset diabetes of the young (MODY) is a heterogeneous group

Maturity-onset diabetes of the young (MODY) is a heterogeneous group Over the years, different forms of maturity-onset diabetes of the young (MODY) have been identified, with mutations in a number of different genes associated with a MODY-like phenotype. Depending on the

More information

Vignette for Fletcher2013b: master regulators of FGFR2 signalling and breast cancer risk.

Vignette for Fletcher2013b: master regulators of FGFR2 signalling and breast cancer risk. Vignette for Fletcher2013b: master regulators of FGFR2 signalling and breast cancer risk. Mauro AA Castro *, Michael NC Fletcher *, Xin Wang, Ines de Santiago, Martin O Reilly, Suet-Feung Chin, Oscar M

More information

A computational approach to identify microrna (mirna) based biomarker from the regulation of disease pathology.

A computational approach to identify microrna (mirna) based biomarker from the regulation of disease pathology. Research Article http://www.alliedacademies.org/biology-and-medicine-case-report/ A computational approach to identify microrna (mirna) based biomarker from the regulation of disease pathology. Anandaram

More information

15. Supplementary Figure 9. Predicted gene module expression changes at 24hpi during HIV

15. Supplementary Figure 9. Predicted gene module expression changes at 24hpi during HIV Supplementary Information Table of content 1. Supplementary Table 1. Summary of RNAseq data and mapping statistics 2. Supplementary Table 2. Biological functions enriched in 12 hpi DE genes, derived from

More information

TRANSCRIPTION FACTORS in ONCOGENESIS

TRANSCRIPTION FACTORS in ONCOGENESIS TRANSCRIPTION FACTORS in ONCOGENESIS 19 10 2018 TRANSCRIPTION Basal transcription TAF TBP TATAA IIA RNA Polimerasi IIB IIF IIE IIH Transcription factors Gene-specific Tissue-specific Time-specific Enhancer

More information

SUPPLEMENTARY FIG. S2. b-galactosidase staining of

SUPPLEMENTARY FIG. S2. b-galactosidase staining of SUPPLEMENTARY FIG. S1. b-galactosidase staining of senescent cells in 500 mg=dl glucose (10 magnification). SUPPLEMENTARY FIG. S3. Toluidine blue staining of chondrogenic-differentiated adipose-tissue-derived

More information

Supplementary Table S1. Primers used for quantitative real-time polymerase chain reaction. Marker Sequence (5 3 ) Accession No.

Supplementary Table S1. Primers used for quantitative real-time polymerase chain reaction. Marker Sequence (5 3 ) Accession No. Supplementary Tables Supplementary Table S1. Primers used for quantitative real-time polymerase chain reaction Marker Sequence (5 3 ) Accession No. Angiopoietin 1, ANGPT1 A CCCTCCGGTGAATATTGGCTGG NM_001146.3

More information

Genome Control in Cell Identity and Disease! Development and cell identity Loss of cell identity and disease New diagnostics and therapeutics

Genome Control in Cell Identity and Disease! Development and cell identity Loss of cell identity and disease New diagnostics and therapeutics Genome Control in Cell Identity and Disease! Development and cell identity Loss of cell identity and disease New diagnostics and therapeutics Development and cell identity! 30,000,000,000 cells!! Control

More information

Supplemental Table 1: List of genes contained on the custom Steroltalk v2 microarray prepared for this study

Supplemental Table 1: List of genes contained on the custom Steroltalk v2 microarray prepared for this study Supplemental Table 1: List of genes contained on the custom Steroltalk v2 microarray prepared for this study Gene GenBank No. Description Ch25h NM_009890 Cholesterol 25-hydroxylase Bile acid synthesis

More information

Supplementary Figure 1. 1,000-cell Scale Nano-ChIPseq Validation Comparison between small-scale ChIPseq (ie Nano-ChIPseq) and Standard ChIPseq for

Supplementary Figure 1. 1,000-cell Scale Nano-ChIPseq Validation Comparison between small-scale ChIPseq (ie Nano-ChIPseq) and Standard ChIPseq for Supplementary Figure 1. 1,000-cell Scale Nano-ChIPseq Validation Comparison between small-scale ChIPseq (ie Nano-ChIPseq) and Standard ChIPseq for K27me3 in murine ES cells. A representative Genome Browser

More information

Nuclear Receptor Monoclonal Antibodies

Nuclear Receptor Monoclonal Antibodies High affinity and specificity 研究用 Research www.funakoshi.co.jp Use Only Nuclear Receptor Monoclonal Antibodies All antibodies are validated by reactivity with proteins from full length cdna expressed in

More information

Pathway Map Reference Guide

Pathway Map Reference Guide Pathway Map Reference Guide Focus Attention-grabber Your Pathway The most popular cell signaling pathways Sample & Assay Technologies Table of contents AKT Signaling 4 camp Signaling 5 Cellular Apoptosis

More information

Nuclear Receptor Profiling

Nuclear Receptor Profiling 1. Overview Nuclear Receptors (NRs) act as transcription factors that mediate the effects of certain hormones, drugs and other xenobiotics by modulating the expression of specific genes involved in many

More information

Hematopoietic Lineage Commitment: Role of Transcription Factors

Hematopoietic Lineage Commitment: Role of Transcription Factors Hematopoietic Lineage Commitment: Role of Transcription Factors John H. Kehrl B Cell Molecular Immunology Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases,

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION doi:10.1038/nature19360 Supplementary Tables Supplementary Table 1. Number of monoclonal reads in each sample Sample Number of cells Total reads Aligned reads Monoclonal reads

More information

Inferring the Mammalian Cardiogenic Gene Regulatory Network. Jason Bazil 10/18/13 Cardiac Physiome Workshop 2013

Inferring the Mammalian Cardiogenic Gene Regulatory Network. Jason Bazil 10/18/13 Cardiac Physiome Workshop 2013 Inferring the Mammalian Cardiogenic Gene Regulatory Network Jason Bazil 1/18/13 Cardiac Physiome Workshop 213 Reverse Engineering Gene Regulatory Networks Two main questions need addressed: 1) What s connected

More information

Non-Size Indications for Aortic Replacement

Non-Size Indications for Aortic Replacement Blood Test for Thoracic Aortic Aneurysm 2 nd International Meeting on Aortic Diseases September 30-October 2, 2010 Liege, Belgium John A. Elefteriades, MD William W.L. Glenn Professor of Cardiothoracic

More information

Transcription Regulation and Gene Expression in Eukaryotes FS 08 Co-activators and Co-repressors

Transcription Regulation and Gene Expression in Eukaryotes FS 08 Co-activators and Co-repressors Transcription Regulation and Gene Expression in Eukaryotes FS 08 Co-activators and Co-repressors P. Matthias, April 02, 2008 Co-regulators: a separate class of transcription factors Do not bind to DNA

More information

Supplementary Material Correlation matrices on FP and FN profiles

Supplementary Material Correlation matrices on FP and FN profiles Supplementary Material Correlation matrices on FP and FN profiles The following two tables give the correlation coefficients for the FP profiles and the FN profiles of a single tagging solutions against

More information

Structure and Function of Fusion Gene Products in. Childhood Acute Leukemia

Structure and Function of Fusion Gene Products in. Childhood Acute Leukemia Structure and Function of Fusion Gene Products in Childhood Acute Leukemia Chromosomal Translocations Chr. 12 Chr. 21 der(12) der(21) A.T. Look, Science 278 (1997) Distribution Childhood ALL TEL-AML1 t(12;21)

More information

Financial disclosures

Financial disclosures An update on immunohistochemical markers in mesenchymal neoplasms By Konstantinos Linos MD, FCAP, FASDP Assistant Professor of Pathology Geisel School of Medicine at Dartmouth Dartmouth-Hitchcock Medical

More information

Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction

Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction Disclosures An update on ancillary techniques in the diagnosis of soft tissue tumors. I have nothing to disclose. Andrew Horvai, MD, PhD Clinical Professor, Pathology Introduction Ancillary techniques

More information

Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction

Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction Disclosures An update on ancillary techniques in the diagnosis of soft tissue tumors. I have nothing to disclose. Andrew Horvai, MD, PhD Clinical Professor, Pathology Introduction Ancillary techniques

More information

OncoMir Library Cancer Type Target Gene

OncoMir Library Cancer Type Target Gene OncoMir Library Cancer Type Target Gene hsa-let-7a-1 Breast Cancer, Lung Cancer H RAS, HMGA2, CDK6, NRAS hsa-let-7a-2 Breast Cancer, Lung Cancer H RAS, HMGA2, CDK6, NRAS hsa-let-7a-3 Breast Cancer, Lung

More information

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated

More information

UKGTN Testing Criteria

UKGTN Testing Criteria Test name: Neonatal Diabetes 22 Gene Panel UKGTN Testing Criteria Approved name and symbol of disorder/condition(s): See Appendix 1 Approved name and symbol of gene(s): See Appendix 1 number(s): number(s):

More information

Technology from Abcam

Technology from Abcam CD2 (EP222) CD2 is one of the earliest T-cell lineage restricted antigens to appear during T-cell differentiation and only rare CD2+ cells can be found in the bone marrow. Anti-CD2 is a pan-t-cell antigen

More information

Polymorphisms associated with expression of BPIFA1/BPIFB1 and lung disease severity in cystic fibrosis

Polymorphisms associated with expression of BPIFA1/BPIFB1 and lung disease severity in cystic fibrosis Polymorphisms associated with expression of BPIFA1/BPIFB1 and lung disease severity in cystic fibrosis Aabida Saferali, Ma en Obeidat, Jean-Christophe Bérubé, Maxime Lamontagne, Yohan Bossé, Michel Laviolette,

More information

Hox Genes: Embryonic Development

Hox Genes: Embryonic Development Thomas Lufkin, Mount Sinai School of Medicine, New York, USA Four clustered gene complexes of DNA-binding transcriptional regulators known as the Hox genes are the principal directors of embryonic development

More information

Table S1. Metadata for transcriptome interaction network and pathway analysis of 5448 intracelluarly infected TEpi cells in comparison to mock TEpi cells. Gene symbol Full name Log2FC gene expression in

More information

Molecular Cell Biology - Problem Drill 10: Gene Expression in Eukaryotes

Molecular Cell Biology - Problem Drill 10: Gene Expression in Eukaryotes Molecular Cell Biology - Problem Drill 10: Gene Expression in Eukaryotes Question No. 1 of 10 1. Which of the following statements about gene expression control in eukaryotes is correct? Question #1 (A)

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature13173 Supplementary Table 1. List of genes commonly expressed in all single cells. Name Actb Actin, beta, cytoplasmic Actg1 Actin, gamma, cytoplasmic 1 Atp5e ATP synthase, H+ transporting,

More information

ONCOGENES. Michael Lea

ONCOGENES. Michael Lea ONCOGENES 2011 Michael Lea ONCOGENES - Lecture Outline I. Introduction 2. Identification of oncogenic genes in retroviruses 3. Homologous sequences in transformed and untransformed cells 4. Methods of

More information

Supplementary Material

Supplementary Material Supplementary Material Taghon, Yui, and Rothenberg: Mast cell diversion of T-lineage precursor cells by the essential T-lineage transcription factor GATA Supplemental Table Supplemental Figures 1-6 Supplemental

More information

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated

More information

mirna Dr. S Hosseini-Asl

mirna Dr. S Hosseini-Asl mirna Dr. S Hosseini-Asl 1 2 MicroRNAs (mirnas) are small noncoding RNAs which enhance the cleavage or translational repression of specific mrna with recognition site(s) in the 3 - untranslated region

More information

Cutaneous Mesenchymal Neoplasms with EWSR1 Rearrangement

Cutaneous Mesenchymal Neoplasms with EWSR1 Rearrangement Cutaneous Mesenchymal Neoplasms with EWSR1 Rearrangement By Konstantinos Linos MD, FCAP, FASDP Bone, Soft Tissue and Dermatopathology Assistant Professor of Pathology Dartmouth-Hitchcock Medical Center

More information

Cancer genetics

Cancer genetics Cancer genetics General information about tumorogenesis. Cancer induced by viruses. The role of somatic mutations in cancer production. Oncogenes and Tumor Suppressor Genes (TSG). Hereditary cancer. 1

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the author to give readers additional information about his work. Supplement to: Croce CM. Oncogenes and cancer. N Engl J Med 2008;358:502-11.

More information

TNFSF13B tumor necrosis factor (ligand) superfamily, member 13b NF-kB pathway cluster, Enrichment Score: 3.57

TNFSF13B tumor necrosis factor (ligand) superfamily, member 13b NF-kB pathway cluster, Enrichment Score: 3.57 Appendix 2. Highly represented clusters of genes in the differential expression of data. Immune Cluster, Enrichment Score: 5.17 GO:0048584 positive regulation of response to stimulus GO:0050778 positive

More information

Supplementary Data. Reference

Supplementary Data. Reference Supplementary Data Supplementary Methods Cloning of the mir-155 and mir-221/222 genes Genomic DNA was isolated from hmsc-tert20 cells using the High Pure PCR Template Preparation Kit (Roche Applied Science,

More information

Table S5: List of 152 differentially expressed genes in anti-gal-1 versus scramble JJN3

Table S5: List of 152 differentially expressed genes in anti-gal-1 versus scramble JJN3 Table S5: List of 152 differentially expressed genes in anti-gal-1 versus scramble JJN3 comparison specific after re-oxygenation process. Gene.symbol Variation Gene Name FOS -1.049641012 v-fos FBJ murine

More information

Molecular Markers in Acute Leukemia. Dr Muhd Zanapiah Zakaria Hospital Ampang

Molecular Markers in Acute Leukemia. Dr Muhd Zanapiah Zakaria Hospital Ampang Molecular Markers in Acute Leukemia Dr Muhd Zanapiah Zakaria Hospital Ampang Molecular Markers Useful at diagnosis Classify groups and prognosis Development of more specific therapies Application of risk-adjusted

More information

Transcription and chromatin. General Transcription Factors + Promoter-specific factors + Co-activators

Transcription and chromatin. General Transcription Factors + Promoter-specific factors + Co-activators Transcription and chromatin General Transcription Factors + Promoter-specific factors + Co-activators Cofactor or Coactivator 1. work with DNA specific transcription factors to make them more effective

More information

Regionalization of the nervous system. Paul Garrity 7.68J/9.013J February 25, 2004

Regionalization of the nervous system. Paul Garrity 7.68J/9.013J February 25, 2004 Regionalization of the nervous system Paul Garrity 7.68J/9.013J February 25, 2004 Patterning along: Rostral/Caudal (AP) axis Dorsal/Ventral (DV) axis Start with DV axial patterning in Spinal Cord Dorsal/Ventral

More information

CNRS, UPR 9079, Institut André Lwoff, 7, rue Guy Moquet, Bât. B, 1er étage, Villejuif, France (VG, HY, SASA)

CNRS, UPR 9079, Institut André Lwoff, 7, rue Guy Moquet, Bât. B, 1er étage, Villejuif, France (VG, HY, SASA) Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Deep Insight Section Transcription factors Valentina Guasconi, Hakima Yahi, Slimane Ait-Si-Ali CNRS, UPR

More information

Howard Temin. Predicted RSV converted its genome into DNA to become part of host chromosome; later discovered reverse transciptase.

Howard Temin. Predicted RSV converted its genome into DNA to become part of host chromosome; later discovered reverse transciptase. Howard Temin Predicted RSV converted its genome into DNA to become part of host chromosome; later discovered reverse transciptase Nobel prize 1975 Figure 3.6 The Biology of Cancer ( Garland Science 2007)

More information

Molecular Hematopathology Leukemias I. January 14, 2005

Molecular Hematopathology Leukemias I. January 14, 2005 Molecular Hematopathology Leukemias I January 14, 2005 Chronic Myelogenous Leukemia Diagnosis requires presence of Philadelphia chromosome t(9;22)(q34;q11) translocation BCR-ABL is the result BCR on chr

More information

U118MG. Supplementary Figure 1 U373MG U118MG 3.5 A CCF-SSTG

U118MG. Supplementary Figure 1 U373MG U118MG 3.5 A CCF-SSTG A172 CCF-SSTG1 15 - - - 1 1 1 2 2 3 4 6 7 8 10101112131617192022-1 1 1 2 2 3 4 6 7 8 10 10 11 12 13 16 17 19 20 22 T98G U373MG - - - 1 1 1 2 2 3 4 6 7 8 10 10 11 12 13 16 17 19 20 22-1 1 1 2 2 3 4 6 7

More information

Seq-ing Answers to Questions of Transcriptional Regulation and Epigenetics. Theodore J. Perkins OttBUG Seminar Nov.

Seq-ing Answers to Questions of Transcriptional Regulation and Epigenetics. Theodore J. Perkins   OttBUG Seminar Nov. Seq-ing Answers to Questions of Transcriptional Regulation and Epigenetics Theodore J. Perkins www.perkinslab.ca OttBUG Seminar Nov. 7, 2016 Outline ChIP-seq What s it for? How does it work? Two examples

More information

REGULATORY MECHANISMS OF TRANSCRIPTION FACTOR FUNCTION

REGULATORY MECHANISMS OF TRANSCRIPTION FACTOR FUNCTION Transcription Regulation And Gene Expression in Eukaryotes Cycle G2 (lecture 13709) RG Clerc 04.04.2012 REGULATORY MECHANISMS OF TRANSCRIPTION FACTOR FUNCTION Protein synthesized Protein phosphorylated

More information

NEW IHC A n t i b o d i e s

NEW IHC A n t i b o d i e s NEW IHC Antibodies TABLE OF CONTENTS NEW IHC ANTIBODIES from Cell Marque CITED1 (5H6).... 1 Claudin 7 (5D10F3).... 1 GATA1 (4F5).... 1 Transgelin (2A10C2).... 1 NEW IHC ANTIBODIES using RabMAb Technology

More information

Loss of LMO4 in the retina leads to reduction of GABAergic amacrine cells and functional deficits. Philippe Martin Duquette

Loss of LMO4 in the retina leads to reduction of GABAergic amacrine cells and functional deficits. Philippe Martin Duquette Loss of LMO4 in the retina leads to reduction of GABAergic amacrine cells and functional deficits. Philippe Martin Duquette This thesis is submitted as a partial fulfillment of the M.Sc. program in Cellular

More information

Nuclear receptors. Lecture 4. Never work alone: corepressors and coactivators

Nuclear receptors. Lecture 4. Never work alone: corepressors and coactivators Nuclear receptors Lecture 4 Never work alone: corepressors and coactivators General transcription factors Eucaryotic RNA polymerases cannot initiate transcription on their own; they require a set of proteins

More information

SUPPLEMENTARY DATA. Assessment of cell survival (MTT) Assessment of early apoptosis and cell death

SUPPLEMENTARY DATA. Assessment of cell survival (MTT) Assessment of early apoptosis and cell death Overexpression of a functional calcium-sensing receptor dramatically increases osteolytic potential of MDA-MB-231 cells in a mouse model of bone metastasis through epiregulinmediated osteoprotegerin downregulation

More information

Rho GTPase activating protein 8 /// PRR5- ARHGAP8 fusion

Rho GTPase activating protein 8 /// PRR5- ARHGAP8 fusion Probe Set ID RefSeq Transcript ID Gene Title Gene Symbol 205980_s_at NM_001017526 /// NM_181334 /// NM_181335 Rho GTPase activating protein 8 /// PRR5- ARHGAP8 fusion ARHGAP8 /// LOC553158 FC ALK shrna

More information

Regulation of the expression of zinc finger protein genes by micrornas enriched within acute lymphoblastic leukemia-derived microvesicles

Regulation of the expression of zinc finger protein genes by micrornas enriched within acute lymphoblastic leukemia-derived microvesicles Regulation of the expression of zinc finger protein genes by micrornas enriched within acute lymphoblastic leukemia-derived microvesicles L. Lu 1 *, X.M. Chen 1 *, H.M. Tao 1, W. Xiong 1, S.H. Jie 2 and

More information

Lung Met 1 Lung Met 2 Lung Met Lung Met H3K4me1. Lung Met H3K27ac Primary H3K4me1

Lung Met 1 Lung Met 2 Lung Met Lung Met H3K4me1. Lung Met H3K27ac Primary H3K4me1 a Gained Met-VELs 1.5 1.5 -.5 Lung Met 1 Lung Met Lung Met 3 1. Lung Met H3K4me1 Lung Met H3K4me1 1 Lung Met H3K4me1 Lung Met H3K7ac 1.5 Lung Met H3K7ac Lung Met H3K7ac.8 Primary H3K4me1 Primary H3K7ac

More information

CELL CYCLE MOLECULAR BASIS OF ONCOGENESIS

CELL CYCLE MOLECULAR BASIS OF ONCOGENESIS CELL CYCLE MOLECULAR BASIS OF ONCOGENESIS Summary of the regulation of cyclin/cdk complexes during celll cycle Cell cycle phase Cyclin-cdk complex inhibitor activation Substrate(s) G1 Cyclin D/cdk 4,6

More information

The generation of antibody-secreting plasma cells

The generation of antibody-secreting plasma cells REVIEWS The generation of antibody-secreting plasma cells Stephen L. Nutt, Philip D. Hodgkin, David M. Tarlinton and Lynn M. Corcoran Abstract The regulation of antibody production is linked to the generation

More information

Supplementary Table S1: Gene expression targets

Supplementary Table S1: Gene expression targets Supplementary Table S1: Gene expression targets Probe ID Gene ID Gene Descriptions Cell type Antigen-dependent activation MmugDNA.32422.1.S1_at CD180 CD180 molecule B 1 MmugDNA.18254.1.S1_at CD19 CD19

More information

11 -Hydroxysteroid dehydrogenase, expression, corticotroph adenomas 68 70

11 -Hydroxysteroid dehydrogenase, expression, corticotroph adenomas 68 70 Subject Index Activin activity decrease, gonadotroph 78 pituitary tumorigenesis, role 99 Adenoma, see also specific cell types angiogenesis, see Angiogenesis clonality, see Clonality, pituitary tumors

More information

Lecture 22. Regulation of gene expression by type II nuclear receptors

Lecture 22. Regulation of gene expression by type II nuclear receptors Lecture 22 Regulation of gene expression by type II nuclear receptors The nuclear receptor superfamily Hypervariable DBD LBD Type I receptors They undergo nuclear translocation upon ligand activation and

More information

Predicting interactome network perturbations in human cancer: application to gene fusions in acute lymphoblastic leukemia

Predicting interactome network perturbations in human cancer: application to gene fusions in acute lymphoblastic leukemia MBoC ARTICLE Predicting interactome network perturbations in human cancer: application to gene fusions in acute lymphoblastic leukemia Leon Juvenal Hajingabo a, Sarah Daakour b, Maud Martin b, Reinhard

More information

INTERACTION DRUG BODY

INTERACTION DRUG BODY INTERACTION DRUG BODY What the drug does to the body What the body does to the drug Receptors - intracellular receptors - membrane receptors - Channel receptors - G protein-coupled receptors - Tyrosine-kinase

More information

Supplementary Table SI: Y strain T. cruzi infection results in the upregulation of 381 genes at the site of infection.

Supplementary Table SI: Y strain T. cruzi infection results in the upregulation of 381 genes at the site of infection. Supplementary Table SI: Y strain T. cruzi infection results in the upregulation of 381 genes at the site of infection. Genes found to be significantly upregulated (FDR2) in Y strain

More information

VIII Curso Internacional del PIRRECV. Some molecular mechanisms of cancer

VIII Curso Internacional del PIRRECV. Some molecular mechanisms of cancer VIII Curso Internacional del PIRRECV Some molecular mechanisms of cancer Laboratorio de Comunicaciones Celulares, Centro FONDAP Estudios Moleculares de la Celula (CEMC), ICBM, Facultad de Medicina, Universidad

More information

THE ROLE OF ONCOGENES IN HEMATOLOGIC MALIGNANCIES

THE ROLE OF ONCOGENES IN HEMATOLOGIC MALIGNANCIES BOXER Annu. ONCOGENES Rev. Med. 1994. IN HEMATOLOGIC 45:1 11 MALIGNANCIES Copyright 1994 by Annual Reviews Inc. All rights reserved THE ROLE OF ONCOGENES IN HEMATOLOGIC MALIGNANCIES Linda M. Boxer, M.D.,

More information

Eukaryotic transcription (III)

Eukaryotic transcription (III) Eukaryotic transcription (III) 1. Chromosome and chromatin structure Chromatin, chromatid, and chromosome chromatin Genomes exist as chromatins before or after cell division (interphase) but as chromatids

More information

In Vitro Differentiation and Expansion of Human Pluripotent Stem Cell-Derived Pancreatic Progenitors

In Vitro Differentiation and Expansion of Human Pluripotent Stem Cell-Derived Pancreatic Progenitors Reprint from The Review of DIABETIC STUDIES Vol 11 No 1 2014 Special Edition Stem Cells and Pancreas Regeneration The Review of DIABETIC STUDIES REVIEW In Vitro Differentiation and Expansion of Human Pluripotent

More information

* Kyoto Encyclopedia of Genes and Genomes.

* Kyoto Encyclopedia of Genes and Genomes. Supplemental Material Complete gene expression data using Affymetrix 3PRIME IVT ID Chip (54,614 genes) and human immature dendritic cells stimulated with rbmasnrs, IL-8 and control (media) has been deposited

More information

Biochemistry 673 Lecture 2 Jason Kahn, UMCP Introduction to steroid hormone receptor (nuclear receptor) signalling

Biochemistry 673 Lecture 2 Jason Kahn, UMCP Introduction to steroid hormone receptor (nuclear receptor) signalling Biochemistry 673 Lecture 2 Jason Kahn, UMCP Introduction to steroid hormone receptor (nuclear receptor) signalling Resources: Latchman Lodish chapter 10, 20 Helmreich, chapter 11 http://www.nursa.org,

More information

Prof. R. V. Skibbens. Cell Cycle, Cell Division and Cancer (Part 2)

Prof. R. V. Skibbens. Cell Cycle, Cell Division and Cancer (Part 2) Prof. R. V. Skibbens November 22, 2010 BIOS 10: BioScience in the 21 st Century Cell Cycle, Cell Division and Cancer (Part 2) Directionality - clocks go in only one direction G1 doesn t have replication-inducing

More information

DAX1, testes development role 7, 8 DFFRY, spermatogenesis role 49 DMRT genes, male sex differentiation role 15

DAX1, testes development role 7, 8 DFFRY, spermatogenesis role 49 DMRT genes, male sex differentiation role 15 Subject Index N-Acetylcysteine, sperm quality effects 71 Ambiguous genitalia, origins 1, 2 Anti-Müllerian hormone function 13 receptors 13 Sertoli cell secretion 10, 38 Apoptosis assays in testes 73, 74

More information

35 th UKCCG Meeting. Joint UKCCG and CHO Annual Conference. 9 th 10 th April 2013 Newcastle upon Tyne

35 th UKCCG Meeting. Joint UKCCG and CHO Annual Conference. 9 th 10 th April 2013 Newcastle upon Tyne 35 th UKCCG Meeting Joint UKCCG and CHO Annual Conference 9 th 10 th April 2013 Newcastle upon Tyne Welcome! 35 th UKCCG Meeting Joint UK Cancer Cytogenetics Group and Centre Haemato-Oncology Annual Conference

More information

Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4

Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4 Khozoie et al. BMC Genomics 2012, 13:665 RESEARCH ARTICLE Open Access Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4 Combiz Khozoie

More information

Genetics and Cancer Ch 20

Genetics and Cancer Ch 20 Genetics and Cancer Ch 20 Cancer is genetic Hereditary cancers Predisposition genes Ex. some forms of colon cancer Sporadic cancers ~90% of cancers Descendants of cancerous cells all cancerous (clonal)

More information

Tetrapod Limb Development

Tetrapod Limb Development IBS 8102 Cell, Molecular and Developmental Biology Tetrapod Limb Development February 11, 2008 Tetrapod Limbs Merlin D. Tuttle Vicki Lockard and Paul Barry Father Alejandro Sanchez Anne Fischer Limb Patterning

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION 1 2 3 4 5 6 7 8 9 10 11 ON-LINE SUPPLEMENTARY MATERIAL FOR THE HUMAN MAPPING Summary of clinical cases: Proband # 1: Case described in Mitchell et al 17 IV-2 in this pedigree. A baby girl born to Pakistani

More information

ELSEVIER: UNCORRECTED PROOF

ELSEVIER: UNCORRECTED PROOF Glucagon Gene Expression DANIEL J. DRUCKER University of Toronto I. PROGLUCAGON GENE STRUCTURE AND POSTTRANSLATIONAL PROGLUCAGON PROCESSING II. PROGLUCAGON GENE EXPRESSION IN THE PANCREAS III. PROGLUCAGON

More information

Determination Differentiation. determinated precursor specialized cell

Determination Differentiation. determinated precursor specialized cell Biology of Cancer -Developmental Biology: Determination and Differentiation -Cell Cycle Regulation -Tumor genes: Proto-Oncogenes, Tumor supressor genes -Tumor-Progression -Example for Tumor-Progression:

More information

Genetic factors in hypospadias

Genetic factors in hypospadias Genetic factors in hypospadias Loes FM van der Zanden Radboud university medical center, Nijmegen, Netherlands Department for Health Evidence, Loes.vanderZanden@radboudumc.nl AGORA project Aetiologic research

More information

Supplementary Table 1. Genes analysed for expression by angiogenesis gene-array.

Supplementary Table 1. Genes analysed for expression by angiogenesis gene-array. Supplementary Table 1. Genes analysed for expression by angiogenesis gene-array. Gene symbol Gene name TaqMan Assay ID UniGene ID 18S rrna 18S ribosomal RNA Hs99999901_s1 Actb actin, beta Mm00607939_s1

More information

Chapt 15: Molecular Genetics of Cell Cycle and Cancer

Chapt 15: Molecular Genetics of Cell Cycle and Cancer Chapt 15: Molecular Genetics of Cell Cycle and Cancer Student Learning Outcomes: Describe the cell cycle: steps taken by a cell to duplicate itself = cell division; Interphase (G1, S and G2), Mitosis.

More information

Entrez Symbols Name TermID TermDesc IGFIRC,Igf1r,JTK13 insulin-like growth factor 1 receptor 4520 Adherens junction Af6,Mllt4

Entrez Symbols Name TermID TermDesc IGFIRC,Igf1r,JTK13 insulin-like growth factor 1 receptor 4520 Adherens junction Af6,Mllt4 Entrez Symbols Name TermID TermDesc 25718 IGFIRC,Igf1r,JTK13 insulin-like growth factor 1 receptor 4520 Adherens junction 26955 Af6,Mllt4 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog,

More information

Additional file 2 List of pathway from PID

Additional file 2 List of pathway from PID Additional file 2 List of pathway from PID Pathway ID Pathway name # components # enriched GO terms a4b1_paxdep_pathway Paxillin-dependent events mediated by a4b1 20 179 a4b1_paxindep_pathway Paxillin-independent

More information

Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber

Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber jweber@dom.wustl.edu Oncogenes & Cancer DNA Tumor Viruses Simian Virus 40 p300 prb p53 Large T Antigen Human Adenovirus p300 E1A

More information

Supporting Information

Supporting Information Supporting Information Siddappa et al. 10.1073/pnas.0711190105 Fig. S1. (a) Percentage ALP-positive cells in hmscs grown in basic medium (Con), osteogenic medium (Dex), basic medium supplemented with 1

More information

Validated Mouse Quantitative RT-PCR Genes Gene Gene Bank Accession Number Name

Validated Mouse Quantitative RT-PCR Genes Gene Gene Bank Accession Number Name 5HT1a NM_008308.4 Serotonin Receptor 1a 5HT1b NM_010482.1 Serotonin Receptor 1b 5HT2a NM_172812.2 Serotonin Receptor 2a ACO-2 NM_080633.2 Aconitase 2 Adora2A NM_009630.02 Adenosine A2a Receptor Aif1 (IbaI)

More information

Fayth K. Yoshimura, Ph.D. September 7, of 7 RETROVIRUSES. 2. HTLV-II causes hairy T-cell leukemia

Fayth K. Yoshimura, Ph.D. September 7, of 7 RETROVIRUSES. 2. HTLV-II causes hairy T-cell leukemia 1 of 7 I. Diseases Caused by Retroviruses RETROVIRUSES A. Human retroviruses that cause cancers 1. HTLV-I causes adult T-cell leukemia and tropical spastic paraparesis 2. HTLV-II causes hairy T-cell leukemia

More information

Polarity and Segmentation. Chapter Two

Polarity and Segmentation. Chapter Two Polarity and Segmentation Chapter Two Polarization Entire body plan is polarized One end is different than the other Head vs. Tail Anterior vs. Posterior Front vs. Back Ventral vs. Dorsal Majority of neural

More information

Cell cycle, signaling to cell cycle, and molecular basis of oncogenesis

Cell cycle, signaling to cell cycle, and molecular basis of oncogenesis Cell cycle, signaling to cell cycle, and molecular basis of oncogenesis MUDr. Jiří Vachtenheim, CSc. CELL CYCLE - SUMMARY Basic terminology: Cyclins conserved proteins with homologous regions; their cellular

More information

Statistical Issues in Translational Cancer Research

Statistical Issues in Translational Cancer Research Statistical Issues in Translational Cancer Research Martin Bøgsted Department of Haematology Aalborg University Hospital and Department of Clinical Medicine Aalborg University The only useful function

More information

oncogenes-and- tumour-suppressor-genes)

oncogenes-and- tumour-suppressor-genes) Special topics in tumor biochemistry oncogenes-and- tumour-suppressor-genes) Speaker: Prof. Jiunn-Jye Chuu E-Mail: jjchuu@mail.stust.edu.tw Genetic Basis of Cancer Cancer-causing mutations Disease of aging

More information

A bioinformatics driven cancer study

A bioinformatics driven cancer study The 11th China-Japan-Korea Bioinformatics Training Course & Symposium, June 16-18, Suzhou, China A bioinformatics driven cancer study Chao Li and Yixue Li yxli@sibs.ac.cn Shanghai Institutes for Bio-Medicine

More information

Lecture 8. Eukaryotic gene regulation: post translational modifications of histones

Lecture 8. Eukaryotic gene regulation: post translational modifications of histones Lecture 8 Eukaryotic gene regulation: post translational modifications of histones Recap.. Eukaryotic RNA polymerases Core promoter elements General transcription factors Enhancers and upstream activation

More information